Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice

被引:880
作者
Lu, B
Rutledge, BJ
Gu, L
Fiorillo, J
Lukacs, NW
Kunkel, SL
North, R
Gerard, C
Rollins, BJ
机构
[1] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Childrens Hosp, Perlmutter Lab, Boston, MA 02115 USA
[3] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48105 USA
[4] Trudeau Inst Inc, Saranac Lake, NY 12983 USA
关键词
D O I
10.1084/jem.187.4.601
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Monocyte chemoattractant protein 1 (MCP-1) is a CC chemokine that attracts monocytes, memory T lymphocytes, and natural killer cells. Because other chemokines have similar target cell specificities and because CCR2, a cloned MCP-1 receptor, binds other ligands, it has been uncertain whether MCP-1 plays a unique role in recruiting mononuclear cells in vivo. To address this question, we disrupted SCYA2 (the gene encoding MCP-1) and tested MCP-1-deficient mice in models of inflammation. Despite normal numbers of circulating leukocytes and resident macrophages, MCP-1(-/-) mice were specifically unable to recruit monocytes 72 h after intraperitoneal thioglycollate administration. Similarly, accumulation of F4/80+ monocytes in delayed-type hypersensitivity lesions was impaired, although the swelling response was normal. Development of secondary pulmonary granulomata in response to Schistosoma mansoni was blunted in MCP-1(-/-) mice, as was expression of IL-4, IL-5, and interferon gamma in splenocytes. In contrast, MCP-1(-/-) mice were indistinguishable from wild-type mice in their ability to clear Mycobacterium tuberculosis. Our data indicate that MCP-1 is uniquely essential for monocyte recruitment in several inflammatory models in vivo and influences expression of cytokines related to T helper responses.
引用
收藏
页码:601 / 608
页数:8
相关论文
共 50 条
[1]   INDUCTION OF NATURAL-KILLER-CELL MIGRATION BY MONOCYTE CHEMOTACTIC PROTEIN-1, PROTEIN-2 AND PROTEIN-3 [J].
ALLAVENA, P ;
BIANCHI, G ;
ZHOU, D ;
VANDAMME, J ;
JILEK, P ;
SOZZANI, S ;
MANTOVANI, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (12) :3233-3236
[2]   MONOCLONAL-ANTIBODY TO MURINE PECAM-1 (CD31) BLOCKS ACUTE-INFLAMMATION IN-VIVO [J].
BOGEN, S ;
PAK, J ;
GARIFALLOU, M ;
DENG, XH ;
MULLER, WA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) :1059-1064
[3]   Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice [J].
Boring, L ;
Gosling, J ;
Chensue, SW ;
Kunkel, SL ;
Farese, RV ;
Broxmeyer, HE ;
Charo, IF .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) :2552-2561
[4]   THE ROLE OF CYTOKINES IN THE FORMATION OF THE SCHISTOSOME EGG GRANULOMA [J].
BOROS, DL .
IMMUNOBIOLOGY, 1994, 191 (4-5) :441-450
[5]  
BOZIC CR, 1995, J IMMUNOL, V154, P6048
[6]   MONOCYTE CHEMOATTRACTANT PROTEIN-1 ACTS AS A T-LYMPHOCYTE CHEMOATTRACTANT [J].
CARR, MW ;
ROTH, SJ ;
LUTHER, E ;
ROSE, SS ;
SPRINGER, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3652-3656
[7]  
Chensue SW, 1996, J IMMUNOL, V157, P4602
[8]  
CHENSUE SW, 1995, AM J PATHOL, V146, P130
[9]  
COMBADIERE C, 1995, J BIOL CHEM, V270, P29671
[10]  
ERNST CA, 1994, J IMMUNOL, V152, P3541